Compare Novartis with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs REMEDIUM LIFECARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS REMEDIUM LIFECARE NOVARTIS/
REMEDIUM LIFECARE
 
P/E (TTM) x 88.8 48.6 182.8% View Chart
P/BV x 2.8 13.3 21.3% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 NOVARTIS   REMEDIUM LIFECARE
EQUITY SHARE DATA
    NOVARTIS
Mar-21
REMEDIUM LIFECARE
Mar-20
NOVARTIS/
REMEDIUM LIFECARE
5-Yr Chart
Click to enlarge
High Rs77023 3,407.1%   
Low Rs50114 3,540.6%   
Sales per share (Unadj.) Rs154.58.0 1,924.0%  
Earnings per share (Unadj.) Rs8.50.8 1,100.1%  
Cash flow per share (Unadj.) Rs13.40.8 1,662.2%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.29.3 3,104.6%  
Shares outstanding (eoy) m24.693.60 685.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.12.3 179.8%   
Avg P/E ratio x75.123.9 314.4%  
P/CF ratio (eoy) x47.522.8 208.1%  
Price / Book Value ratio x2.22.0 111.4%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,69166 23,720.3%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0852 58,972.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,81429 13,195.5%  
Other income Rs m3320-   
Total revenues Rs m4,14629 14,344.3%   
Gross profit Rs m2674 6,876.3%  
Depreciation Rs m1220 93,538.5%   
Interest Rs m770-   
Profit before tax Rs m4004 10,677.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1911 19,530.6%   
Profit after tax Rs m2093 7,545.1%  
Gross profit margin %7.013.4 52.1%  
Effective tax rate %47.826.1 182.9%   
Net profit margin %5.59.6 57.2%  
BALANCE SHEET DATA
Current assets Rs m9,22440 22,847.4%   
Current liabilities Rs m3,5735 65,312.6%   
Net working cap to sales %148.2120.8 122.7%  
Current ratio x2.67.4 35.0%  
Inventory Days Days1760-  
Debtors Days Days37189 19.6%  
Net fixed assets Rs m2,4802 107,350.6%   
Share capital Rs m12336 342.8%   
"Free" reserves Rs m7,018-2 -285,284.6%   
Net worth Rs m7,14134 21,292.2%   
Long term debt Rs m04 0.0%   
Total assets Rs m11,70343 27,421.0%  
Interest coverage x6.2NM-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.30.7 48.1%   
Return on assets %2.46.5 37.6%  
Return on equity %2.98.3 35.4%  
Return on capital %6.710.1 66.3%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-692-2 35,132.0%  
From Investments Rs m952-2 -39,000.0%  
From Financial Activity Rs m-3683 -12,777.8%  
Net Cashflow Rs m-109-2 7,091.5%  

Share Holding

Indian Promoters % 0.0 8.4 -  
Foreign collaborators % 73.4 0.0 -  
Indian inst/Mut Fund % 1.3 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.6 91.6 29.0%  
Shareholders   44,652 845 5,284.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   NARBADA GEMS  SVP GLOBAL  EMPOWER INDUSTRIES  SEACOAST SHIPPING SERVICES  NAGARJUNA AGRI TECH  



Today's Market

Sensex Ends Above 60,000-Mark, Nifty Tops 17,850; Asian Paints & Eicher Motors Climb 3%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

A Great Time to Buy ITC(Profit Hunter)

Sep 17, 2021

Is the worst over for the stock of ITC?

Top Small Caps to Buy Now(Views On News)

Sep 18, 2021

Rahul Shah on why he would invest in these unusual 20 small cap stocks

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Sep 24, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS